Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
View ORCID ProfileGennadi V. Glinsky
doi: https://doi.org/10.1101/2020.10.03.20206151
Gennadi V. Glinsky
1Institute of Engineering in Medicine, University of California, San Diego, 9500 Gilman Dr. MC 0435, La Jolla, CA 92093-0435, USA
Data Availability
All data referred to in the manuscript and note are available.
Posted October 12, 2020.
Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
Gennadi V. Glinsky
medRxiv 2020.10.03.20206151; doi: https://doi.org/10.1101/2020.10.03.20206151
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2971)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12821)
- Forensic Medicine (12)
- Gastroenterology (832)
- Genetic and Genomic Medicine (4625)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4415)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7010)
- Radiology and Imaging (1549)
- Respiratory Medicine (922)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)